Robert Ferris, MD
Otolaryngology · Raleigh, NCNPI 1851364509
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $171,384 of the $257,795 with a category attached, or 66.5%. 30 manufacturers reported payments, led by Merck at 27.5% of the total. 2025 is the largest year on record at $108,945, 2.9 times the $38,225 reported in 2019. Among otolaryngology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 233 payments — averaging $1106.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$71K
- Regeneron Healthcare Solutions, Inc.$44K
- Regeneron$31K
- Pfizer$19K
- Merck Kgaa$14K
- E.r. Squibb & Sons, L.L.C.$13K
- plus $66K from 24 others
Across 96 payments — averaging $23,445 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$1.2M
- Merck$863K
- Hoffmann-la Roche Limited$76K
- Foundation Medicine, Inc.$66K
- Genentech, Inc.$17K
- Macrogenics, Inc.$13K
- plus $1K from 1 others
What the payments were for
- Consulting fees$171,38466%
- Speaking & faculty fees$37,69315%
- Travel & lodging$41,85316%
- Food & beverage$6,8653%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 58 | $70,952 |
| Regeneron Healthcare Solutions, Inc. | 27 | $44,421 |
| Regeneron | 38 | $31,158 |
| Pfizer | 8 | $18,597 |
| Merck Kgaa | 3 | $13,755 |
| E.r. Squibb & Sons, L.L.C. | 20 | $13,291 |
| GSK | 13 | $11,677 |
| F. Hoffmann-la Roche AG | 2 | $9,920 |
| Astrazeneca UK Limited | 10 | $9,889 |
| Eisai Inc. | 2 | $7,300 |
| Janssen Research & Development, LLC | 2 | $4,380 |
| Lilly USA, LLC | 1 | $3,942 |
| Coherus Oncology, Inc. | 5 | $2,820 |
| Sanofi | 1 | $2,480 |
| Novartis | 1 | $2,170 |
| EMD Serono, Inc. | 1 | $2,000 |
| Genentech, Inc. | 4 | $1,935 |
| Hoffmann-la Roche Limited | 4 | $1,598 |
| Astrazeneca AB | 8 | $1,355 |
| Kowa Research Institute, Inc. | 1 | $1,240 |
| Seagen Inc. | 1 | $1,030 |
| AstraZeneca | 6 | $428 |
| Arcutis Biotherapeutics, Inc. | 4 | $369 |
| Johnson & Johnson(2 entities) | 3 | $270 |
| Journey Medical Corporation | 2 | $243 |
| Novocure Inc. | 1 | $140 |
| Bayer | 3 | $138 |
| Sun Pharmaceutical Industries Inc. | 1 | $106 |
| Janssen Scientific Affairs, LLC | 1 | $98 |
| Amgen | 2 | $91 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$257,795 in reported general payments places this provider in the 95th percentile of 362 otolaryngology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 22 | $170 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Raleigh
- Jeevan RamakrishnanRaleigh$12K
- Brett DorfmanRaleigh$6K
- Viraj PatelRaleigh$5K
- Nicolas George KatsantonisRaleigh$5K
- Kevin DoyleRaleigh$4K
- David JangDurham$324K
- Adam ZanationHickory$227K
- Brent SeniorChapel Hill$91K
- Charles EbertChapel Hill$57K
- Adam CampbellWinston Salem$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.